highly significantp < 0.0005
These findings suggest that the potent antitumor activity of irinotecan is further enhanced by TG6002/5-FC, with the combination showing highly significant efficacy compared to controls ( p < 0.0005).
These findings suggest that the potent antitumor activity of irinotecan is further enhanced by TG6002/5-FC, with the combination showing highly significant efficacy compared to controls ( p < 0.0005).